Ify Osunkwo: We invite you to join our interactive roundtable discussion

Ify Osunkwo, Chief Patient Officer at Novo Nordisk, shared on LinkedIn:

“A rare opportunity for an important discussion-We look forward to seeing you soon in Barcelona!

If you are attending the Orphan Drug Congress on 31 October 2023, why not join me Dr. Ify Osunkwo, alongside my colleagues Lora Ruth Wogu, and David-Zacharie Issom for an interactive roundtable discussion? Together, we’ll dive deep into one of the most pressing themes affecting the Rare Disease community: How can we ignite integrated, equitable, and affordable access to care?

During the discussion, we will explore the challenges people living with sickle cell face when trying to receive proper care and discuss how they can be addressed at multiple levels by each stakeholder across the healthcare system – from R&D, data collection and patient engagement to ensuring better collaborations between patient associations, industry, and health authorities, guided by the principles of patient advocacy. Leveraging these insights, we will discuss how to take these learnings forward to accelerate access to care so that more people living with rare diseases can get the treatment they deserve.

Get insights and perspectives on:
• What challenges exist for people living with sickle cell disease?
• How can these challenges be solved efficiently across the healthcare continuum?
• Why is partnership key to ensuring integrated, equitable, affordable access to care?

And how to take these learnings forward!

We invite you to join our interactive roundtable discussion: Ensuring integrated, equitable and affordable access to care: sickle cell disease as a case study.

Join us at WODC on:
Oct. 31st, 11:30 – 12:30 CEST and let’s discuss!

Source: Ify Osunkwo/LinkedIn.